Want to see TSE:MGRO full AI Analyst Report?
MustGrow Biologics (MGRO) Income Statement
MustGrow Biologics Income Statement
Last quarter (Q2 2026), MustGrow Biologics's total revenue was $1.44M, a decrease of 49.52% from the same quarter last year. In Q2, MustGrow Biologics's net income was $284.69K. See MustGrow Biologics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 8.29M | $ 398.02K | $ 4.71M | $ 6.48K | $ 12.87K | |
| $ 1.41M | $ 300.75K | $ 4.33M | $ 6.48K | $ 12.87K | |
| $ 7.66M | $ 5.41M | $ 5.52M | $ 5.69M | $ 3.02M | |
| Depreciation and Amortization | $ 50.76K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| $ -6.20M | $ -4.89M | $ -676.94K | $ -5.56M | $ -3.01M | |
| $ -6.25M | $ -5.11M | $ -804.99K | $ -5.56M | $ -3.01M | |
| $ -1.01M | $ 225.45K | $ 128.05K | $ -10.07K | $ -52.77K | |
| $ -7.26M | $ -4.89M | $ -676.94K | $ -5.57M | $ -3.06M | |
| $ -7.26M | $ -4.89M | $ -676.94K | $ -5.57M | $ -3.06M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.13 | $ -0.09 | $ -0.01 | $ -0.11 | $ -0.07 |
| Diluted EPS | $ -0.13 | $ -0.09 | $ -0.01 | $ -0.11 | $ -0.07 |
| Weighted Average Shares Outstanding | 54.35M | 51.60M | 49.89M | 49.01M | 43.74M |
| Weighted Average Shares Outstanding (Diluted) | 54.35M | 51.60M | 49.89M | 49.01M | 43.74M |
Currency in CAD